Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20133798 | 0.90 | — | — | |
| SCHEMBL18649218 | 0.85 | ALDH1A1 (0.33) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL22825416 | 0.78 | KDM4E (0.31) | ALDH1A1KDM4E | |
| SCHEMBL10029427 | 0.77 | HRH3 (0.37) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL13566591 | 0.76 | L3MBTL1 (0.30) | — | |
| SCHEMBL2233257 | 0.76 | ALDH1A1 (0.32) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL14246510 | 0.75 | ALDH1A1 (0.40) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL34468662 | 0.75 | ALDH1A1 (0.36) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL30523298 | 0.75 | ALDH1A1 (0.36) | ALDH1A1NPSR1POLBMAPTHTT | |
| SCHEMBL21562371 | 0.75 | ALDH1A1 (0.36) | ALDH1A1NPSR1POLBMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336781-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2019-07-02 | — | — | US | disclosed |
| US-10316255-B2 | Conversion of lipids into olefins | UNIV ALBERTA (CA) | 2019-06-11 | — | — | US | disclosed |
| US-10183899-B2 | Normal alpha olefin synthesis using metathesis and dehydroformylation | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2019-01-22 | — | — | US | disclosed |
| US-20190002766-A1 | CONVERSION OF LIPIDS INTO OLEFINS | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2019-01-03 | — | — | US | disclosed |
| US-20170335051-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING POLYMER | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | THE TRUSTEES OF BOSTON COLLEGE | 2016-06-16 | — | — | US | disclosed |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | HOVEYDA AMIR H | 2010-11-18 | — | — | US | disclosed |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | HOVEYDA AMIR H | 2010-11-18 | — | — | US | disclosed |
| US-7723255-B2 | Recyclable metathesis catalysts | THE TRUSTEES OF BOSTON COLLEGE (US) | 2010-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10183899-B2 | Normal alpha olefin synthesis using metathesis and dehydroformylation | DHPS, CYP8B1, FDFT1 | ALDH1A1 10/4885NPSR1 2391/4885POLB 1233/4885 |
| US-20100292486-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885NPSR1 3329/4885POLB 1951/4885 |
| US-10336781-B2 | Recyclable metathesis catalysts | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885NPSR1 3329/4885POLB 1951/4885 |
| US-20160168181-A1 | RECYCLABLE METATHESIS CATALYSTS | DNMT1, CARM1, ZMYND8 | ALDH1A1 2343/4885NPSR1 3329/4885POLB 1951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.